The conventional manufacturing process for the generation of activated CAR-T cells can typically take 7 to 9 days or even longer. Resilience has developed a 3-day short cycle process for generated T-cells that were of high purity, activated, and transduced.
WHAT YOU WILL LEARN IN THIS WHITE PAPER:
-
Why adopting a short cycle process into the CAR-T cell manufacturing landscape is highly desirable.
-
Benefits of the CAR-T cell 3-day process, including enhanced biological activity by means of increased IFN-γ release and cytotoxic activity when compared to CAR-T cells generated in a conventional 7-day manufacturing process.
-
How the Resilience 3-day short cycle process is capable of reducing turn around time, reducing costs for production (less time, materials, and labor).
Download the white paper (PDF) by completing the form below:
